To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Launched by CHANG GUNG MEMORIAL HOSPITAL · Jan 14, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a program called Enhanced Recovery After Surgery (ERAS) can help patients who are having surgery for pituitary tumors. The aim is to see if this program can improve recovery and reduce complications after surgery. The trial is currently recruiting participants who are between 18 and 80 years old and have been diagnosed with a pituitary tumor. To join, individuals need to provide written consent and meet certain health criteria.

Participants in the trial can expect to receive care guided by the ERAS principles, which focus on helping patients recover more quickly after surgery. However, those with other serious health issues, such as severe infections, certain blood disorders, or who are pregnant, cannot take part. This study is important because it could lead to better recovery practices for patients undergoing surgery for pituitary tumors, ultimately improving their overall experience and outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of pituitary tumors
• • To sign a written informed consent form
• Exclusion Criteria:
• • Diagnosed with other malignant tumors
• • Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
• • Pregnant women
• • Coagulation disorders or those taking anticoagulant medication
• • Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment
• • Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment